The Intersection of Informatics and Diabetes: Harnessing Technology to Improve Care

Alexander Singer,Conrad Pow,Braden O'Neill

DOI: https://doi.org/10.1016/j.jcjd.2023.12.005

IF: 2.774

2024-02-18

Canadian Journal of Diabetes

Abstract:A.S. and B.O. are co-leads of the Diabetes Action Canada National Diabetes Repository. C.P. is a Senior Lead for Digital Health, Diabetes Action Canada.

endocrinology & metabolism

What problem does this paper attempt to address?

Advances in diabetes technology within the digital diabetes ecosystem

Halis Kaan Akturk,Anila Bindal

DOI: https://doi.org/10.18553/jmcp.2024.30.10-b.s7

Abstract:Ongoing innovations in glucose monitoring, insulin delivery, and telehealth technologies have created a digital diabetes ecosystem populated by connected tools and technologies that have been shown to improve clinical outcomes, lower costs, and reduce the burden of diabetes. Advances in connected continuous glucose monitoring devices, insulin pumps, and insulin pens have led to the development of automated insulin delivery systems that modulate insulin infusion based on sensor glucose data. Similar integrations of continuous glucose monitoring and connected blood glucose meter data into "smart" pens have lessened the guesswork of intensive insulin management for individuals who prefer traditional injection therapy. A growing number of health apps that can be accessed through smartphones and wearable devices provide information and advice that support individuals in adopting healthier lifestyles. The differences in features and functionality give users the ability to select the devices that best meet their unique requirements and preferences. This article reviews the most current digital diabetes technologies and discusses how the connectivity of these tools can create an overarching architecture of feedback mechanisms that monitor an individual's health status, motivate and enhance adherence to self-management, and provide advice and decision-support tools to clinicians as well as other members of the health care team to make living with diabetes more manageable.
A Digital Ecosystem of Diabetes Data and Technology

Nathaniel D. Heintzman

DOI: https://doi.org/10.1177/1932296815622453

2015-12-20

Journal of Diabetes Science and Technology

Abstract:The management of type 1 diabetes (T1D) ideally involves regimented measurement of various health signals; constant interpretation of diverse kinds of data; and consistent cohesion between patients, caregivers, and health care professionals (HCPs). In the context of myriad factors that influence blood glucose dynamics for each individual patient (eg, medication, activity, diet, stress, sleep quality, hormones, environment), such coordination of self-management and clinical care is a great challenge, amplified by the routine unavailability of many types of data thought to be useful in diabetes decision-making. While much remains to be understood about the physiology of diabetes and blood glucose dynamics at the level of the individual, recent and emerging medical and consumer technologies are helping the diabetes community to take great strides toward truly personalized, real-time, data-driven management of this chronic disease. This review describes “connected” technologies—such as smartphone apps, and wearable devices and sensors—which comprise part of a new digital ecosystem of data-driven tools that can link patients and their care teams for precision management of diabetes. These connected technologies are rich sources of physiologic, behavioral, and contextual data that can be integrated and analyzed in “the cloud” for research into personal models of glycemic dynamics, and employed in a multitude of applications for mobile health (mHealth) and telemedicine in diabetes care.
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology

Steve Edelman,Wayman W Cheatham,Anna Norton,Kelly L Close

DOI: https://doi.org/10.2337/cd23-0003

Abstract:Diabetes technology continues to evolve, advancing with our understanding of human biology and improving our ability to treat people with diabetes. Diabetes devices are broadly classified into the following categories: glucose sensors, insulin delivery devices, and digital health care technology (i.e., software and mobile applications). When supported by education and individually tailored, technology can play a key role in optimizing outcomes. Digital devices assist in diabetes management by tracking meals, exercise, sleep, and glycemic measurements in real time, all of which can guide physicians and other clinicians in their decision-making. Here, as people with diabetes and patient advocates, as well as diabetes specialists, primary care providers, and diabetes care and education specialists, we present our perspectives on the advances, benefits, and challenges of diabetes technology in primary care practices.
The critical elements of digital health in diabetes and cardiometabolic care

Mansur Shomali,Pablo Mora,Grazia Aleppo,Malinda Peeples,Abhimanyu Kumbara,Janice MacLeod,Anand Iyer

DOI: https://doi.org/10.3389/fendo.2024.1469471

2024-09-16

Abstract:Digital innovations provide novel opportunities to individualize a person's care to best match their lifestyle needs and circumstances and to support them as they live their daily lives with diabetes. These innovations also serve to provide actionable data and insights for the care team giving them a "Webb telescope-like" view into their individual self-management journey, allowing them to see what cannot be seen during infrequent and limited office visits, thereby facilitating collaboration and communication to optimize the care plan on a timely basis. Technology advances are enabling diabetes care to transition from episodic, synchronous, primarily in-person care to include synchronous virtual care options and to continuous, on-demand, data-informed, asynchronous digital care better matching the demands of living with a relentless 24/7 chronic condition. In this paper we will discuss the critical elements and considerations in designing and implementing successful diabetes digital health tools in clinical practice.
Artificial Intelligence for Diabetes Case Management: The Intersection of Physical and Mental Health

Casey C. Bennett

DOI: https://doi.org/10.1016/j.imu.2019.100191

2019-05-11

Abstract:Diabetes is a major public health problem in the United States, affecting roughly 30 million people. Diabetes complications, along with the mental health comorbidities that often co-occur with them, are major drivers of high healthcare costs, poor outcomes, and reduced treatment adherence in diabetes. Here, we evaluate in a large state-wide population whether we can use artificial intelligence (AI) techniques to identify clusters of patient trajectories within the broader diabetes population in order to create cost-effective, narrowly-focused case management intervention strategies to reduce development of complications. This approach combined data from: 1) claims, 2) case management notes, and 3) social determinants of health from ~300,000 real patients between 2014 and 2016. We categorized complications as five types: Cardiovascular, Neuropathy, Opthalmic, Renal, and Other. Modeling was performed combining a variety of machine learning algorithms, including supervised classification, unsupervised clustering, natural language processing of unstructured care notes, and feature engineering. The results showed that we can predict development of diabetes complications roughly 83.5% of the time using claims data or social determinants of health data. They also showed we can reveal meaningful clusters in the patient population related to complications and mental health that can be used to cost-effective screening program, reducing the number of patients to be screened down by 85%. This study outlines creation of an AI framework to develop protocols to better address mental health comorbidities that lead to complications development in the diabetes population. Future work is described that outlines potential lines of research and the need for better addressing the 'people side' of the equation.

Quantitative Methods,Artificial Intelligence,Machine Learning
Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?

Osagie Ebekozien,Kathryn Fantasia,Farnoosh Farrokhi,Ashutosh Sabharwal,David Kerr

DOI: https://doi.org/10.1111/dom.15470

2024-02-02

Diabetes Obesity and Metabolism

Abstract:Digital health technologies are being utilized increasingly in the modern management of diabetes. These include tools such as continuous glucose monitoring systems, connected blood glucose monitoring devices, hybrid closed‐loop systems, smart insulin pens, telehealth, and smartphone applications (apps). Although many of these technologies have a solid evidence base, from the perspective of a person living with diabetes, there remain multiple barriers preventing their optimal use, creating a digital divide. In this article, we describe many of the origins of these barriers and offer recommendations on widening access to digital health technologies for underserved populations living with diabetes to improve their health outcomes.

endocrinology & metabolism
Artificial intelligence and machine learning in diabetes research

Phong Nguyen,Alexander J. Ohnmacht,Ana Galhoz,Maren Buettner,Fabian Theis,Michael P. Menden

DOI: https://doi.org/10.1007/s11428-021-00817-w

2021-01-01

Abstract:Background Diabetes mellitus is becoming a global health issue which demands a transformation of the research and healthcare practice for better patient management. To this end, the abundance of data and advancements in technology and artificial intelligence provides opportunities for such an endeavour. Aims This review aims to provide an overview of diabetes, artificial intelligence and the current research in diabetes which involve artificial intelligence in risk prediction, diagnosis, prognosis and prediction of complications. Conclusion Artificial intelligence is transforming diabetes research in many technical and organizational aspects. Although its deployment is still limited and is facing many challenges, it will likely impact future patient care by providing automated and personalized healthcare for patients.
Diabetes education reimagined: educator-led, technology-enabled diabetes population health management services

Sacha Uelmen,Janice MacLeod

DOI: https://doi.org/10.1016/b978-0-12-817485-2.00002-x

2020-01-01

Abstract:People have come to depend on technology in their daily lives to communicate, perform daily tasks, and seek out information. They are increasingly expecting technology also to help them manage their health with tools that allow them to track, monitor, and share lifestyle data with their health-care team. The adoption of technology into health care is rapidly transforming many aspects of health care, including diabetes care and education while empowering individuals to become better informed and more active participants in their own care. This chapter provides an overview of the rapidly expanding role of digital health in diabetes education and care and the evidence supporting its use. It highlights a leadership opportunity for enterprising diabetes care and education specialists to redesign their traditional diabetes education services to incorporate technology-enabled population health management options that can lead the health-care team to efficiently provide better care at lower cost to a growing diabetes population.
Digitalization of Diabetes Care: Clinical Relevance and Application

Ambady Ramachandran

DOI: https://doi.org/10.59556/japi.72.0599

Abstract:Over the years, technological innovations have reshaped our approach toward treating chronic conditions such as diabetes. As you are aware, diabetes is a metabolic disorder requiring lifestyle changes and a lifetime of treatment and continued care. Recently, digital technology has been found to support chronic diabetes care.1 This editorial embarks on the evolution of digital interventions in diabetes care, tracing its trajectory from simple mobile phone messaging to the conceptualization of mobile applications.
A Roadmap to an Equitable Digital Diabetes Ecosystem

David Kerr,David C Klonoff,Richard M Bergenstal,Pratik Choudhary,Linong Ji

DOI: https://doi.org/10.1016/j.eprac.2022.12.016

Abstract:Objectives: Diabetes management presents a substantial burden to individuals living with the condition and their families, health care professionals, and health care systems. Although an increasing number of digital tools are available to assist with tasks such as blood glucose monitoring and insulin dose calculation, multiple persistent barriers continue to prevent their optimal use. Methods: As a guide to creating an equitable connected digital diabetes ecosystem, we propose a roadmap with key milestones that need to be achieved along the way. Results: During the Coronavirus 2019 pandemic, there was an increased use of digital tools to support diabetes care, but at the same time, the pandemic also highlighted problems of inequities in access to and use of these same technologies. Based on these observations, a connected diabetes ecosystem should incorporate and optimize the use of existing treatments and technologies, integrate tasks such as glucose monitoring, data analysis, and insulin dose calculations, and lead to improved and equitable health outcomes. Conclusions: Development of this ecosystem will require overcoming multiple obstacles, including interoperability and data security concerns. However, an integrated system would optimize existing devices, technologies, and treatments to improve outcomes.
Diabetes Technology in the "Real World": Expanding Access and Addressing Disparities

Ananta Addala,Stuart A Weinzimer,Stuart A. Weinzimer

DOI: https://doi.org/10.1089/dia.2024.2512

2024-03-06

Diabetes Technology & Therapeutics

Abstract:This year continues to demonstrate the success of diabetes technology on a grand scale. Real-world data continue to demonstrate the efficacy of diabetes technology and the unwavering persistence of disparities in glycemic outcomes and diabetes technology use. As in prior years, we have again this year showcased several articles that illustrate, primarily in type 1 diabetes (T1D), the continuing improvements in glycemic benchmarks achievable with the application of diabetes technologies available to us today. We then highlight several notable studies related to type 2 diabetes (T2D) and the inpatient care setting, two populations in whom the use of diabetes technologies are vastly underutilized and potentially stand to have the greatest impact to overcome the therapeutic inertia inherent to these clinical care systems. Finally, we highlight the favorable health economics of subsidized diabetes technology and detail interventions at the level of the clinician, clinic, and government to address disparities. These studies on the economic feasibility and evidence-based solutions of expanding access to diabetes technology serve as a call to action for the diabetes community.

endocrinology & metabolism
Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges

Scott C Mackenzie,Chris A R Sainsbury,Deborah J Wake

DOI: https://doi.org/10.1007/s00125-023-06038-8

IF: 8.2

Diabetologia

Abstract:The discourse amongst diabetes specialists and academics regarding technology and artificial intelligence (AI) typically centres around the 10% of people with diabetes who have type 1 diabetes, focusing on glucose sensors, insulin pumps and, increasingly, closed-loop systems. This focus is reflected in conference topics, strategy documents, technology appraisals and funding streams. What is often overlooked is the wider application of data and AI, as demonstrated through published literature and emerging marketplace products, that offers promising avenues for enhanced clinical care, health-service efficiency and cost-effectiveness. This review provides an overview of AI techniques and explores the use and potential of AI and data-driven systems in a broad context, covering all diabetes types, encompassing: (1) patient education and self-management; (2) clinical decision support systems and predictive analytics, including diagnostic support, treatment and screening advice, complications prediction; and (3) the use of multimodal data, such as imaging or genetic data. The review provides a perspective on how data- and AI-driven systems could transform diabetes care in the coming years and how they could be integrated into daily clinical practice. We discuss evidence for benefits and potential harms, and consider existing barriers to scalable adoption, including challenges related to data availability and exchange, health inequality, clinician hesitancy and regulation. Stakeholders, including clinicians, academics, commissioners, policymakers and those with lived experience, must proactively collaborate to realise the potential benefits that AI-supported diabetes care could bring, whilst mitigating risk and navigating the challenges along the way.
Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here

Irene Dankwa-Mullan,Marc Rivo,Marisol Sepulveda,Yoonyoung Park,Jane Snowdon,Kyu Rhee

DOI: https://doi.org/10.1089/pop.2018.0129

Abstract:An estimated 425 million people globally have diabetes, accounting for 12% of the world's health expenditures, and yet 1 in 2 persons remain undiagnosed and untreated. Applications of artificial intelligence (AI) and cognitive computing offer promise in diabetes care. The purpose of this article is to better understand what AI advances may be relevant today to persons with diabetes (PWDs), their clinicians, family, and caregivers. The authors conducted a predefined, online PubMed search of publicly available sources of information from 2009 onward using the search terms "diabetes" and "artificial intelligence." The study included clinically-relevant, high-impact articles, and excluded articles whose purpose was technical in nature. A total of 450 published diabetes and AI articles met the inclusion criteria. The studies represent a diverse and complex set of innovative approaches that aim to transform diabetes care in 4 main areas: automated retinal screening, clinical decision support, predictive population risk stratification, and patient self-management tools. Many of these new AI-powered retinal imaging systems, predictive modeling programs, glucose sensors, insulin pumps, smartphone applications, and other decision-support aids are on the market today with more on the way. AI applications have the potential to transform diabetes care and help millions of PWDs to achieve better blood glucose control, reduce hypoglycemic episodes, and reduce diabetes comorbidities and complications. AI applications offer greater accuracy, efficiency, ease of use, and satisfaction for PWDs, their clinicians, family, and caregivers.
Artificial intelligence for diabetic care

Ankita Kapse,Marina Semin,Rakesh Kumar Jha,Bhushan Bawankar,Praful Patil

DOI: https://doi.org/10.4103/jdmimsu.jdmimsu_275_22

2022-09-28

Journal of Datta Meghe Institute of Medical Sciences University

Abstract:Ankita Kapse, Marina Semin, Rakesh Kumar Jha, Bhushan Bawankar, Praful Patil Journal of Datta Meghe Institute of Medical Sciences University 2022 17(2):487-490 Artificial intelligence (AI) has the potential to enhance results in the future, diabetes care. The goal of this article was to help people with diabetes, their clinicians, families, and caregivers better understand what AI breakthroughs are important now. AI medical applications include diagnosis, categorization, therapy, and robotics, among others. We are no longer confined to descriptive data analysis because we may acquire a larger by recognizing and anticipating patterns coming from inductive reasoning, owing to medical learning. AI applications have the potential to revolutionize diabetic care by assisting millions of people with diabetes in achieving better blood glucose management, reducing hyperglycemic episodes, and lowering diabetic morbidity and complications. We can see the evolution of closed-loop insulin delivery systems with inbuilt AI algorithms to safeguard both hypoglycemia and hyperglycemia in Type 1 diabetes, which have been relatively few attempts in management techniques for diabetes excursions. The medication you choose and how much you take depend on a variety of factors, including your body mass index, which influences beta-cell activity and insulin resistance, among other things. There are great assessments of research that have employed an AI approach to treat diabetes. The only way to deal with vast, diverse datasets is to rely solely on quantitative data. At this point, there are numerous issues with absolute reliance on quantitative data, depending on the frequently poor quality of this sort of information, as well as the necessity to complement combining a quantitative and qualitative approach. Attempting toward the transformation of unstructured data into digitally processed information data is a domain of cognitive computing that is predicted to grow in importance. To make a substantial contribution to AI aside from the purpose, there are 48 other factors to consider.
Addressing Disparities in Diabetes Management Through Novel Approaches to Encourage Technology Adoption and Use

Amy R Sheon,Shari D Bolen,Bill Callahan,Sarah Shick,Adam T Perzynski

DOI: https://doi.org/10.2196/diabetes.6751

2017-07-13

JMIR Diabetes

Abstract:Type 2 diabetes (T2D) is one of the nation's leading drivers of disability and health care utilization, with elevated prevalence among individuals with lower education, income, and racial/ethnic minorities. Health information technology (HIT) holds vast potential for helping patients, providers, and payers to address T2D and the skyrocketing rates of chronic illness and associated health care costs. Patient portals to electronic health records (EHRs) serve as a gateway to consumer use of HIT. We found that disparities in portal use portend growing T2D disparities. Little progress has been made in addressing identified barriers to technology adoption, especially among populations with elevated risk of T2D. Patients often lack digital literacy skills and continuous connectivity and fear loss of the relationship with providers. Providers may experience structural disincentives to promoting patient use of HIT and apply hidden biases that inhibit portal use. Health care systems often provide inadequate training to patients and providers in use of HIT, and lack resources devoted to obtaining and optimizing use of data generated by HIT. Lastly, technology-related barriers include inadequate consideration of user perspectives, lack of evidence for patient-focused apps, and lack of features to enable providers and health care systems to readily obtain aggregate data to improve care and facilitate research. After discussing these barriers in detail, we propose possible solutions and areas where further research is needed to ensure that individuals and health care systems obtain the full benefit of the nation's planned $38 billion HIT investment. A digital inclusion framework sheds new light on barriers posed for patients with social health inequalities. We have determined that partnerships with community organizations focused on digital inclusion could help health systems explore and study new approaches, such as universal screening and referral of patients for digital skills, health literacy, and Internet connectivity.
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction

Moshe Phillip,Richard M Bergenstal,Kelly L Close,Thomas Danne,Satish K Garg,Lutz Heinemann,Irl B Hirsch,Boris P Kovatchev,Lori M Laffel,Viswanathan Mohan,Christopher G Parkin,Tadej Battelino

DOI: https://doi.org/10.1089/dia.2020.0375

Abstract:The increasing prevalence of diabetes, combined with a growing global shortage of health care professionals (HCP), necessitates the need to develop new approaches to diabetes care delivery to expand access to care, lessen the burden on people with diabetes, improve efficiencies, and reduce the unsustainable financial liability on health systems and payers. Use of digital diabetes technologies and telehealth protocols within a digital/virtual diabetes clinic has the potential to address these challenges. However, several issues must be resolved to move forward. In February 2020, organizers of the Advanced Technologies & Treatments for Diabetes Annual Conference convened an international panel of HCP, researchers, patient advocates, and industry representatives to review the status of digital diabetes technologies, characterize deficits in current technologies, and identify issues for consideration. Since that meeting, the importance of using telehealth and digital diabetes technologies has been demonstrated amid the global coronavirus disease (COVID-19) pandemic. This article summarizes the panel's discussion of the opportunities, obstacles, and requisites for advancing the use of these technologies as a standard of care for the management of diabetes.
The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities

Shivani Agarwal,Iman Simmonds,Alyson K. Myers

DOI: https://doi.org/10.1007/s11892-022-01470-3

2022-06-03

Current Diabetes Reports

Abstract:The management of diabetes has been revolutionized by the introduction of novel technological treatments and modalities of care, such as continuous glucose monitoring, insulin pump therapy, and telehealth. While these technologies have demonstrated improvement in health outcomes, it remains unclear whether they have reduced inequities from racial/ethnic minority or socioeconomic status. We review the current literature to discuss evidence of benefit, current limitations, and future opportunities of diabetes technologies.

endocrinology & metabolism
Artificial intelligence in diabetes management: Advancements, opportunities, and challenges

Zhouyu Guan,Huating Li,Ruhan Liu,Chun Cai,Yuexing Liu,Jiajia Li,Xiangning Wang,Shan Huang,Liang Wu,Dan Liu,Shujie Yu,Zheyuan Wang,Jia Shu,Xuhong Hou,Xiaokang Yang,Weiping Jia,Bin Sheng

DOI: https://doi.org/10.1016/j.xcrm.2023.101213

2023-10-17

Abstract:The increasing prevalence of diabetes, high avoidable morbidity and mortality due to diabetes and diabetic complications, and related substantial economic burden make diabetes a significant health challenge worldwide. A shortage of diabetes specialists, uneven distribution of medical resources, low adherence to medications, and improper self-management contribute to poor glycemic control in patients with diabetes. Recent advancements in digital health technologies, especially artificial intelligence (AI), provide a significant opportunity to achieve better efficiency in diabetes care, which may diminish the increase in diabetes-related health-care expenditures. Here, we review the recent progress in the application of AI in the management of diabetes and then discuss the opportunities and challenges of AI application in clinical practice. Furthermore, we explore the possibility of combining and expanding upon existing digital health technologies to develop an AI-assisted digital health-care ecosystem that includes the prevention and management of diabetes.
Making diabetes technology accessible to all

Laura M. Nally,Jennifer L. Sherr

DOI: https://doi.org/10.1038/s41591-024-03082-8

IF: 82.9

2024-06-26

Nature Medicine

Abstract:As diabetes technology evolves, implementation of equitable, sustainable, remote patient monitoring will ensure that this technology is accessible to everyone with type 1 diabetes — but strategies to address the burden of data collection and review are crucial.

biochemistry & molecular biology,cell biology,medicine, research & experimental
The Intersection of Artificial Intelligence and Precision Endocrinology

Dimitrios Vlachakis,Konstantina Dragoumani,Eleni Papakonstantinou,George P Chrousos

DOI: https://doi.org/10.14806/ej.30.0.1052

Abstract:Bioinformatics and artificial intelligence (AI) have emerged as transformative tools in modern medicine, revolutionising the landscape of medical diagnosis and treatment. Herein, we provide an overview of the synergistic relationship between bioinformatics and AI, elucidating their pivotal roles in deciphering complex biological data and advancing precision medicine and, in particular, endocrinology. We explore various applications of bioinformatics and AI in medical research, including genomic analysis, drug discovery, disease diagnosis, and personalised treatment strategies. Additionally, we discuss challenges and future directions in leveraging these technologies to enhance healthcare outcomes.

The Intersection of Informatics and Diabetes: Harnessing Technology to Improve Care

Advances in diabetes technology within the digital diabetes ecosystem

A Digital Ecosystem of Diabetes Data and Technology

Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology

The critical elements of digital health in diabetes and cardiometabolic care

Artificial Intelligence for Diabetes Case Management: The Intersection of Physical and Mental Health

Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?

Artificial intelligence and machine learning in diabetes research

Diabetes education reimagined: educator-led, technology-enabled diabetes population health management services

Digitalization of Diabetes Care: Clinical Relevance and Application

A Roadmap to an Equitable Digital Diabetes Ecosystem

Diabetes Technology in the "Real World": Expanding Access and Addressing Disparities

Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges

Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here

Artificial intelligence for diabetic care

Addressing Disparities in Diabetes Management Through Novel Approaches to Encourage Technology Adoption and Use

The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction

The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities

Artificial intelligence in diabetes management: Advancements, opportunities, and challenges

Making diabetes technology accessible to all

The Intersection of Artificial Intelligence and Precision Endocrinology